Evaluation of myocardial contractility determination with tissue tracking echocardiography after levosimendan infusion in patients with poor left ventricular function and hemodynamics

Heart Surgery Forum

Volumn 17, Issue 6, 2014, Pages E313-E318

  Sahin, Veysel ^a   Uyar, Ihsan Sami ^a   Gul, Ilker ^a   Akpinar, Mehmet Besir ^a   Abacilar, Ahmet Feyzi ^a   Uc, Halil ^a   Okur, Faik Fevzi ^a   Tavli, Talat ^a   Ates, Mehmet ^a   Alayunt, Emin Alp ^a  

^a SIFA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE; LEVOSIMENDAN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; ECHOCARDIOGRAPH; FEMALE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WEANING; ADVERSE EFFECTS; COMPLICATION; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG THERAPY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELASTOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PYRIDAZINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84921455036     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.2014415     Document Type: Article

References (22)

1. Aksun M, Karahan N, Adanir T, et al. 2009. Timing of levosimendan in cardiac surgery. Anatolian J Cardiol 9:223-30.
2. Alvarez J, Bouzada M, Fernandez AL, et al. 2006. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 59:338-45.
3. Borges AC, Kivelitz D, Walde T, et al. 2003. Apical tissue tracking echocardiography for characterization of regional left ventricular function: comparison with magnetic resonance imaging in patients after myocardial infarction. J Am Soc Echocardiogr 16:254-62.
4. D'hooge J, Heimdal A, Jamal F, et al. 2000. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 1:154-70.
5. De Hert SG, Lorsomradee S, Cromheecke S, et al. 2007. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anest Analg 104:766-73.
6. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. 2006. Evidence-based use of levosimendan in different clinical settings. Review. Eur Heart J 27:1908-20.
7. Fabiato A, Fabiato F. 1979. Calcium and cardiac excitation-contraction coupling. Ann Rev Physiol 41:473.
8. Figgitt D P, Gillies PS, Goa KL. 2001. Levosimendan. Drugs 61:613-27.
9. Follath F, Cleland JG, Just H, et al. 2002. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196.
10. Goebel B, Arnold R, Koletzki E, et al. 2007. Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individuals: feasibility, normal values and reproducibility. Int J Cardiovasc Imaging 23:149-55.
11. Gray R, Shah PK, Singh B, Conklin C, Matloff JM. 1981. Low cardiac output states after open heart surgery. Comparative hemodynamic effects of dobutamine, dopamine, and norepinephrine plus phentolamine. Chest 80:16-18.
12. Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. 2004. Hemodynamic effects of levosimendan in patients with low output heart failure after cardiac surgery. Int J Clin Pharm Th 42:204-6.
13. Lehmann A, Lang J, Boldt J, Isgro F, Kiessling AH. 2004. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. Med Sci Monit 10:89.
14. Liileberg J, Nieminen MS, Akkila J, et al. 1998. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary bypass grafting. Eur Heart J 19:660-3.
15. Önem G, Saçar M, Aybek H, et al. 2012. Protective effects of cilostazol and levosimendan on lung injury induced by lower limb ischemia-reperfusion. Turkish J Thorac Cardiovasc Surg 20:577-83.
16. Öner S, Kürşat BA, Asuman S, Zuhal A, Aydin B. 1996. The comparison of the inotropic effects of levosimendan and amrinone after ischemia in isolated perfused guinea pig hearts. Turkish J Thorac Cardiovasc Surg 4:5-8.
17. Pan C, Hoffmann R, Kühl H, Severin E, Franke A, Hanrath P. 2001. Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiogr 2:197-202.
18. Romson JL, Leung JM, Bellows WH. 1999. Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology 91:1318-21.
19. Salomon NW, Plachetka JR, Copeland JG. 1981. Comparison of dopamine and dobutamine following coronary artery bypass grafting. Ann Thorac Surg 3:48-51.
20. Sogaard P, Egeblad H, Pedersen AK, et al. 2002. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 106:2078-84.
21. Voigt JU, Flachskampf FA. 2004. Strain and strain rate. New and clinically relevant echo parameters of regional myocardial function. Z Kardiol 93:249-58.
22. Yaʇar S, Yavaş S, Kervan Ü, Balci M, Özgök A. 2012. The effect of highdose GIK infusion on cytokin levels in beating heart coronary artery bypass graft surgery patients with left ventricular dysfunction. Turkish J of Thorac and Cardiovasc Surg 20:39-43.